STOCK TITAN

Celestica (CLS) director granted 127 director share units in Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Celestica Inc. reported an equity compensation transaction by one of its directors on a Form 4. On 12/31/2025, the director acquired 127 director share units, listed as derivative securities with a price of $0, reflecting a grant rather than an open-market purchase.

After this transaction, the director beneficially owns 531 director share units, held directly. According to the disclosure, each director share unit represents a contingent right to receive one common share of Celestica or an equivalent value in cash, at the company’s discretion, when the holder stops serving as a director, consultant or other service provider. This filing highlights ongoing alignment of director compensation with shareholder interests through share-based awards.

Positive

  • None.

Negative

  • None.
Insider Colpron Francoise
Role Director
Type Security Shares Price Value
Grant/Award Director Share Units 127 $0.00 --
Holdings After Transaction: Director Share Units — 531 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Colpron Francoise

(Last) (First) (Middle)
5140 YONGE STREET
SUITE 1900

(Street)
TORONTO A6 M2N 6L7

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Director Share Units (1) 12/31/2025 A 127 (1) (1) Common Shares 127 $0 531 D
Explanation of Responses:
1. Each director share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to serve the Issuer as any of a director, consultant or other service provider.
/s/ Tracy Connelly McGilley, attorney-in-fact 01/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Celestica Inc. (CLS) disclose in this Form 4 filing?

Celestica Inc. disclosed that one of its directors received an equity-based award of 127 director share units as of 12/31/2025, reported as a derivative securities transaction at a price of $0.

How many director share units does the Celestica (CLS) director own after this transaction?

Following the reported transaction, the director beneficially owns 531 director share units, held in direct ownership.

What is a director share unit according to the Celestica (CLS) filing?

Each director share unit represents a contingent right to receive one common share of Celestica or an equivalent value in cash, at the issuer’s discretion, when the holder ceases to serve as a director, consultant or other service provider.

Was the Celestica (CLS) director transaction an open-market purchase or a grant?

The transaction is reported with an acquisition code and a $0 price for the derivative securities, indicating it is an equity award grant rather than an open-market purchase.

How does this Form 4 filing affect Celestica (CLS) shareholders?

The filing shows that a Celestica director continues to receive share-based compensation through director share units, aligning part of their compensation with the company’s common shares over time.

When can the Celestica (CLS) director receive common shares or cash from these units?

The director may receive common shares or an equivalent value in cash, at the issuer’s discretion, when they cease serving the company as a director, consultant or other service provider, as described in the disclosure.